Press Releases

BOSTON, Dec. 11, 2019 /PRNewswire/ -- Patient enrollment is one of the most expensive and delicate aspects of a new clinical trial. Judi // Eligibility, the newest offering within AG Mednet's clinical trial SaaS platform, streamlines central eligibility review workflows in trials, and aggregates data to quickly achieve a final determination. The result is a trial wi

MINNEAPOLIS, Dec. 11, 2019 /PRNewswire/ -- Eligible producers from participating Land O'Lakes co-ops and direct Land O'Lakes Dairy members in Minnesota and Kansas have less than two weeks to enroll in the Land O'Lakes Cooperative Farmer Member Health Plan. For coverage beginning

STAMFORD, Conn., Dec. 11, 2019 /PRNewswire/ -- A recent study by the National Institute for Occupational Health and Safety revealed that cancer is curren

DENVER, Dec. 11, 2019 /PRNewswire/ -- Internationally renowned pulmonologist Kevin K. Brown, MD, has been named the new Chair of the Department of Medicine at National Jewish Health. Dr. Brown's appointment follows a comprehensive national and international search.  He has served as Vice Chair for the Department of Medicine at National

SEOUL, South Korea, Dec. 11, 2019 /PRNewswire/ -- ANYMEDI participated in AI showcase of RSNA 2019 (Radiological Society of North America), held in Chicago, U.S. from December 1st to 6th, exhibiting patient-specific surgic

CINCINNATI, Dec. 11, 2019 /PRNewswire/ -- Point of Care market leader PatientPoint® has named esteemed pharmaceutical and health and wellness industry veteran and POC expert

SILVER SPRING, Md., Dec. 11, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today posted a

SALT LAKE CITY, Dec. 11, 2019 /PRNewswire/ -- CHG Healthcare, the nation's largest privately held healthcare staffing company, has been honored with the

MELBOURNE, Fla., Dec. 11, 2019 /PRNewswire/ -- SunRADON, a Sun Nuclear company and the leading provider of Continuous Radon Monitors (CRMs) for commercial and residential purposes, today announced the approval of its

ROCKVILLE, Md., Dec. 11, 2019 /PRNewswire/ -- Hememics Biotechnologies Inc., ("Hememics" or the "Company") announced that AMVI Partners, a consortium of high net worth Vietnamese investors, has invested $2.5 million into Hememics. The company will use the funds to initiate clinical research for supporting a U.S. Food and Drug Administration